These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8740190)

  • 1. The effect of inhibiting fatty acid oxidation on basal glucose metabolism in Psammomys obesus.
    Barnett M; Habito R; Cameron-Smith D; Yamamoto A; Collier GR
    Horm Metab Res; 1996 Apr; 28(4):165-70. PubMed ID: 8740190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of muscle malonyl-CoA levels in the nutritionally insulin-resistant desert gerbil, Psammomys obesus.
    Shafrir E; Ziv E; Saha AK; Ruderman NB
    Diabetes Metab Res Rev; 2002; 18(3):217-23. PubMed ID: 12112940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-administration of etomoxir and RU-486 mitigates insulin resistance in hepatic and muscular tissues of STZ-induced diabetic rats.
    Bitar MS
    Horm Metab Res; 2001 Oct; 33(10):577-84. PubMed ID: 11607876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of glucose metabolism by free fatty acid availability in septic and nonseptic rats.
    Lang CH; Dobrescu C
    Circ Shock; 1992 Oct; 38(2):91-102. PubMed ID: 1423926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of fatty acid oxidation inhibition on glucose metabolism in diabetic rats.
    Collier GR; Traianedes K; Macaulay SL; O'Dea K
    Horm Metab Res; 1993 Jan; 25(1):9-12. PubMed ID: 8428713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of the inhibition of fatty acid oxidation on pyruvate dehydrogenase complex activity in tissues of lean and obese mice.
    Bryson JM; Cooney GJ; Wensley VR; Phuyal JL; Caterson ID
    Int J Obes Relat Metab Disord; 1996 Aug; 20(8):738-44. PubMed ID: 8856397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etomoxir-induced partial carnitine palmitoyltransferase-I (CPT-I) inhibition in vivo does not alter cardiac long-chain fatty acid uptake and oxidation rates.
    Luiken JJ; Niessen HE; Coort SL; Hoebers N; Coumans WA; Schwenk RW; Bonen A; Glatz JF
    Biochem J; 2009 Apr; 419(2):447-55. PubMed ID: 19138173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of myocardial function and metabolism in diabetic rats by the carnitine palmitoyl transferase inhibitor Etomoxir.
    Schmitz FJ; Rösen P; Reinauer H
    Horm Metab Res; 1995 Dec; 27(12):515-22. PubMed ID: 8750778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paradoxical effects of clofibrate on liver and muscle metabolism in rats. Induction of myotonia and alteration of fatty acid and glucose oxidation.
    Paul HS; Adibi SA
    J Clin Invest; 1979 Aug; 64(2):405-12. PubMed ID: 457859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the carnitine-acyltransferase inhibitor etomoxir on insulin sensitivity, energy expenditure and substrate oxidation in NIDDM.
    Hübinger A; Knode O; Susanto F; Reinauer H; Gries FA
    Horm Metab Res; 1997 Sep; 29(9):436-9. PubMed ID: 9370111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-insulin dependent diabetes mellitus in Psammomys obesus is independent of changes in tissue fatty acid composition.
    Collier GR; Collier FM; Sanigorski A; Walder K; Cameron-Smith D; Sinclair AJ
    Lipids; 1997 Mar; 32(3):317-22. PubMed ID: 9076669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of in vivo fatty acid oxidation blockade on glucose turnover and muscle glucose metabolism during low-dose AICAR infusion.
    Christopher M; Rantzau C; Chen ZP; Snow R; Kemp B; Alford FP
    Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E1131-40. PubMed ID: 16772328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels.
    Stefanovic-Racic M; Perdomo G; Mantell BS; Sipula IJ; Brown NF; O'Doherty RM
    Am J Physiol Endocrinol Metab; 2008 May; 294(5):E969-77. PubMed ID: 18349115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inhibitors of beta-oxidation of fatty acids (review)].
    Kendysh IN
    Vopr Med Khim; 1984; 30(2):18-27. PubMed ID: 6377685
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention of nutritionally induced diabetes by rosiglitazone in the gerbil Psammomys obesus.
    Hefetz S; Ziv E; Jörns A; Lenzen S; Shafrir E
    Diabetes Metab Res Rev; 2006; 22(2):139-45. PubMed ID: 16088969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A fatty acid-induced decrease in pyruvate dehydrogenase activity is an important determinant of beta-cell dysfunction in the obese diabetic db/db mouse.
    Zhou YP; Berggren PO; Grill V
    Diabetes; 1996 May; 45(5):580-6. PubMed ID: 8621007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperglycemia and hyperinsulinemia in the sand rat (Psammomys obesus) with positive or negative energy balance.
    Adler JH
    Isr J Med Sci; 1982 Jan; 18(1):187-91. PubMed ID: 7040298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatty acid metabolism during maturation affects glucose uptake and is essential to oocyte competence.
    Paczkowski M; Schoolcraft WB; Krisher RL
    Reproduction; 2014 Oct; 148(4):429-39. PubMed ID: 25062802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new therapeutic approach to treat psoriasis by inhibition of fatty acid oxidation by Etomoxir.
    Caspary F; Elliott G; Navé BT; Verzaal P; Rohrbach M; Das PK; Nagelkerken L; Nieland JD
    Br J Dermatol; 2005 Nov; 153(5):937-44. PubMed ID: 16225603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexamethasone-induced impairment in skeletal muscle glucose transport is not reversed by inhibition of free fatty acid oxidation.
    Venkatesan N; Lim J; Bouch C; Marciano D; Davidson MB
    Metabolism; 1996 Jan; 45(1):92-100. PubMed ID: 8544783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.